AbbVie Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 21:31

I'm PortAI, I can summarize articles.

Shares of AbbVie Inc. (ABBV) fell 1.14% to $225.11 on Monday, underperforming compared to competitors Johnson & Johnson, Pfizer, and Amgen. The S&P 500 Index fell 0.53% and the Dow Jones Industrial Average fell 0.90%. AbbVie is 8.05% below its 52-week high of $244.81. Trading volume was 5.2 million, below the 50-day average of 6.2 million.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) slipped 1.14% to $225.11 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. AbbVie Inc. closed 8.05% short of its 52-week high of $244.81, which the company reached on October 1st. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.76% to $205.34, Pfizer Inc. (PFE) fell 1.83% to $25.27, and Amgen Inc. (AMGN) fell 2.31% to $337.49. Trading volume (5.2 M) remained 1.0 million below its 50-day average volume of 6.2 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1631ET